Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 26;13(3):4851-4868.
doi: 10.1002/cphy.c220024.

Serotonergic Control of Gastrointestinal Development, Motility, and Inflammation

Affiliations

Serotonergic Control of Gastrointestinal Development, Motility, and Inflammation

Sarah A Najjar et al. Compr Physiol. .

Abstract

Although it is most well-known for its roles in central nervous system (CNS) function, the vast majority of serotonin, or 5-hydroxytryptamine (5-HT), is produced in the gastrointestinal (GI) tract. 5-HT is synthesized mostly by enterochromaffin (EC) cells of the GI epithelium and, in small part, by neurons of the enteric nervous system (ENS). The GI tract contains an array of broadly distributed 5-HT receptors, which participate in functions such as motility, sensation, inflammation, and neurogenesis. The roles of 5-HT in these functions are reviewed, as well as its role in the pathophysiology of disorders of gut-brain interaction (DGBIs) and inflammatory bowel diseases (IBD). © 2023 American Physiological Society. Compr Physiol 13:4851-4868, 2023.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Expression and distribution of serotonergic cells and axonal fibers in the colonic mucosa and the enteric nervous system (ENS).
Serotonin (5-hydroxytryptamine, 5-HT)-positive cells (green) are present in both the enterochromaffin (EC) cells of the mucosa (A) and within myenteric plexus of the ENS (B). In the mucosa, 5-HT is expressed in EC cells (starred in inset) which make up less than 1% of gut epithelial cells (stained with nuclei marker, bisbenzimide, magenta). In the myenteric plexus, 5-HT+ neurons (arrow, inset) comprise 2% to 3% of total myenteric neurons (stained with pan-neuronal marker, ANNA-1, magenta) as observed in wholemount laminar preparation of the myenteric plexus (B) and a cross-section of the colon (arrow). In the ENS, 5-HT is also present in continuous presynaptic fibers that run across the enteric ganglia and along interganglionic fiber tracts, thus providing extensive innervation to other neurons within the ganglion. Made in © BioRender - biorender.com.
Figure 2
Figure 2. Serotonin (5-HT) biosynthesis and metabolism in the gastrointestinal tract.
Biosynthesis of 5-HT in the gut is accomplished by two different isoforms of the rate-limiting enzyme, tryptophan hydroxylase (TPH). TPH1 is responsible for 5-HT synthesis in the mucosal enterochromaffin cells and TPH2 synthesizes 5-HT in enteric neurons. Both enzymes convert the amino acid l-tryptophan (l-Tryp) to 5-hydroxytryptophan (5-HTP). The enzyme l-amino acid decarboxylase (l-AAD) then converts 5-HTP to 5-HT where it is then released into the extracellular space (solid arrows) to act on 5-HT receptors and initiate downstream serotonergic signaling. Extracellular 5-HT is then taken back up into EC cells or enteric neurons via the 5-HT transporter, SERT (dashed arrows). Once intracellular, 5-HT is inactivated by monoamine oxidase (MAO), in the mitochondria, to 5-hydroxyindoleacetic acid (5-HIAA). Made in © BioRender - biorender.com.
Figure 3
Figure 3. Mucosa and neuronal 5-HT in peristaltic reflexes and intestinal motility.
Mucosal 5-HT is released from enterochromaffin (EC) cells upon chemical or mechanical stimulation of the mucosa. A subpopulation of EC cells expresses the mechanoreceptor, Piezo2, that responds to distention/mechanical force causing 5-HT release (Inset). Mucosal 5-HT release causes downstream neuronal activation where intrinsic primary afferent neurons (IPAN) signal from the mucosa to ascending and descending neural pathways in the ENS to initiate contraction and relaxation respectively. Neuronal 5-HT present in a small population of enteric neurons (2% to 3%) project extensively and innervate different functional classes of neurons that drive intestinal motility. Neuronal 5-HT can mediate slow and fast excitatory synaptic transmission as well as play critical roles in the descending inhibitory pathways which culminates to intestinal motility. (A) A bolus of food in the gut lumen stimulates both ascending (Bi and descending (Bii) reflex pathways that work cohesively to propel the food through the gut. Ascending interneurons activate excitatory motor neurons upstream of the stimulus to initiate smooth muscle contraction (Bi, red dotted box) while descending interneurons activate inhibitory motor neurons downstream of the stimulus to initiate smooth muscle relaxation (Bii, blue dotted box). Made in © BioRender - biorender.com.

Similar articles

Cited by

References

    1. Adamec R, Burton P, Blundell J, Murphy DL, Holmes A. Vulnerability to mild predator stress in serotonin transporter knockout mice. Behav Brain Res 170: 126–140, 2006. DOI: 10.1016/j.bbr.2006.02.012. - DOI - PubMed
    1. Alcaino C, Knutson KR, Treichel AJ, Yildiz G, Strege PR, Linden DR, Li JH, Leiter AB, Szurszewski JH, Farrugia G, Beyder A. A population of gut epithelial enterochromaffin cells is mechanosensitive and requires Piezo2 to convert force into serotonin release. Proc Natl Acad Sci USA 115: E7632–E7641, 2018. DOI: 10.1073/pnas.1804938115. - DOI - PMC - PubMed
    1. Andresen V, Montori VM, Keller J, West CP, Layer P, Camilleri M. Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol 6: 545–555, 2008. DOI: 10.1016/j.cgh.2007.12.015. - DOI - PMC - PubMed
    1. Annaházi A, Berger TE, Demir IE, Zeller F, Müller M, Anneser M, Skerra A, Michel K, Schemann M. Metabotropic 5-HT receptor-mediated effects in the human submucous plexus. Neurogastroenterol Motil 34: e14380, 2022. DOI: 10.1111/nmo.14380. - DOI - PubMed
    1. Arreola R, Becerril-Villanueva E, Cruz-Fuentes C, Velasco-Velázquez MA, Garcés-Alvarez ME, Hurtado-Alvarado G, Quintero-Fabian S, Pavón L. Immunomodulatory effects mediated by serotonin. J Immunol Res 2015: 354957, 2015. DOI: 10.1155/2015/354957. - DOI - PMC - PubMed

Publication types